參考文獻
1.Chen CP and Sartorelli P. Proceedings of the international conference on occupational and environmental exposures of skin to chemicals: science and policy—session II: health effects and hazard identification. Reg Toxicol Pharmacol 2005; 41:150-8.
2.Sartorellia P, Ahlers H, Alanko K, Chen CP, Cherrie J, Drexler H, Kezic S, Johanson G, Filon F, Maina G, Montomoli L, Nielsen J. How to improve skin notation. Position paper from a workshop. Reg Toxicol Pharmacol 2007; 49:301-7.
3.Bureau of Labor Statistics (BLS). Occupational injuries and illnesses in the United States. BLS Bulletin No. 2518. Department of Labor, BLS, Washington, DC, USA; 1999.
4.National Institute for Occupational Safety and Health (NIOSH). Pocket guide to chemical hazards. DHHS Publication [CD-ROM]; No. 2005-151. Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), NIOSH, Cincinnati, OH, USA; 2013.
5.行政院勞工委員會。勞工作業環境空氣中有害物容許濃度標準。台北(台灣):中華民國行政院勞工委員會;2003。(民國92年12月31日修正條文)。
6.Ahlers H, Chen CP. Skin notation—past, present, future. Short Course S3.3 presented at the Occupational and Environmental Exposures of Skin to Chemicals (OEESC). Proceedings of the OEESC, 2005 June 12-15, Stockholm, Sweden.
7.American Conference of Governmental Industrial Hygienists (ACGIH). Documentation of the TLVs® and BEIs® with other worldwide occupational exposure values, CD-ROM. Cincinnati, OH, USA: ACGIH; 2006.
8.Ahlers HW, Chen CP, Demchuk E, and Dotson GS. A strategy for improvement of skin notations. DHHS Pub. No. 2009-147. Cincinnati, OH, USA: US National Institute for Occupational Safety and Health; 2009. 80 pp.
9.Chen CP, Boeniger MF, and Ahlers HW. Use of dermal LD50 as a criterion for skin notation. Appl Occup Environ Hyg 2003; 18:154-5.
10.Walker JD, Whittaker C, and McDougal JN. Role of the TSCA Interagency Testing Committee in meeting the U.S. government data needs: designating chemicals for percutaneous absorption rate testing. In: Marzulli FN, Maibach HI, editors. Dermatotoxicology, 5th ed. Washington DC, USA: Taylor & Francis; 1996. p. 371-81.
11.Dotson GS, Chen CP, Gadagbui B, Maier A, Ahlers HW, and Lentz TJ. The evolution of skin notations for occupational risk assessment: A new NIOSH strategy. Reg Toxicol Pharmacol 2011; 61:53-62.
12.Chen CP, Ahlers HW, Dotson GS, Lin YC, Chang WC, Maier A, and Gadagbui B. Efficacy of predictive modeling as a scientific criterion in dermal hazard identification for assignment of skin notations. Reg Toxicol Pharmacol 2011; 61:63-72.
13.Wilschut A, ten Berge WF, Robinson PJ, and McKone TE. Estimating skin permeation: the validation of five mathematical skin permeation models. Chemosphere 1995; 30:1275-96.
14.European Union. Regulation (EC) No 1907/2006 of the european parliament and of the council of 18 december 2006. concerning the registration, evaluation, authorisation and restriction of chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC. Official Journal of the European Union. OJ C 112, 30.4.2004, p. 92 and OJ C 294, 25.11.2005, p. 38.
15.European Union. EC Enterprise and Industry All topics: Chemicals, REACH, accessed: http://ec.europa.eu/enterprise/sectors/chemicals/
reach/index_en.htm (June 30, 2013). Brussels, Belgium: EU; 2013.
16.United Nations Economic Commission for Europe (UNECE). Globally Harmonized System of Classification and Labeling of Chemicals (GHS). ST/SG/AC.10/30/Rev.3. New York, NY, USA and Geneva, Switzerland: UNECE; 2009.
17.吳幸娟、陳振菶:非致癌性物質健康風險評估中不確定性係數之應用與規範研究。IOSH99-A308。臺北,臺灣:行政院勞工委員會勞工安全衛生研究所;2011。
18.陳振菶、吳幸娟、李聯雄、張詩吟:職業暴露限制值制定中健康風險評估之運用。勞工安全衛生研究季刊2013;21(1):53-66。19.National Institute for Occupational Safety and Health (NIOSH). Documentation for Immediately Dangerous to Life or Health Concentrations (IDLHs): Introduction, accesses: http://www.cdc.gov/niosh/idlh/idlhintr.html. Atlanta, GA: NIOSH; 1994.
20.Organisation for Economic Cooperation and Development (OECD). Guideline for Testing of Chemicals 402: acute dermal toxicity. Paris, France: OECD; 1987.
21.29 CFR 1910.1000. Occupational Safety and Health Administration (OSHA). Occupational Safety and Health Standards. Washington, DC: OSHA.
22.National Toxicology Program (NTP). Corrositex®: an in vitro test method for assessing dermal corrosivity potential of chemicals. Research Triangle Park, NC: U.S. Department of Health and Human Services, Public Health Service, NTP, NIH Publication No. 99–4495; 1999a.
23.National Toxicology Program (NTP). The murine local lymph node assay: a test method for assessing the allergic contact dermatitis potential of chemicals/compounds. Research Triangle Park, NC: U.S. Department of Health and Human Services, Public Health Service, NTP, NIH Publication No. 99–4494; 1999b.
24.National Toxicology Program (NTP). Objectives and procedures of NTP studies: 2-year study. In: NTP testing information and study results. Research Triangle Park, NC: U.S. Department of Health and Human Services, Public Health Service, NTP; 2001a.
25.National Toxicology Program (NTP). Objectives and procedures of NTP studies: development toxicity. In: NTP testing information and study results. Research Triangle Park, NC: U.S. Department of Health and Human Services, Public Health Service, NTP; 2001b.
26.National Toxicology Program (NTP). National Toxicology Program Annual Plan for Fiscal Year 2002. Research Triangle Park, NC: U.S. Department of Health and Human Services, Public Health Service, NTP, NIH Publication No. 03–5309; 2002a.
27.National Toxicology Program (NTP). ICCVAM evaluation of EPISKINTM, EpiDermTM (EPI-200), and the rat skin transcutaneous electrical resistance (TER) assay: in vitro test methods for assessing dermal corrosivity potential of chemicals. Research Triangle Park, NC: U.S. Department of Health and Human Services, Public Health Service, NTP, NIH Publication No. 02–4502; 2002b.
28.U.S. Environmental Protection Agency (USEPA). Test methods for evaluating solid waste, physical/chemical methods, SW–846 Method 1120: dermal corrosion. Washington, DC: U.S. Environmental Protection Agency, Office of Solid Waste, EPA Publication SW–846 Manual, 3rd ed. Washington, DC: U.S. Environmental Protection Agency, Office of Solid Waste. Washington, DC, USA: USEPA; 1996.
29.U.S. Environmental Protection Agency (USEPA). Health effects test guidelines OPPTS 870.1200: acute dermal toxicity. Washington, DC: U.S. Environmental Protection Agency, Office of Prevention, Pesticides and Toxic Substances, EPA 712–C–98–192. Washington, DC, USA: USEPA; 1998a.
30.U.S. Environmental Protection Agency (USEPA). Health effects test guidelines OPPTS 870.3200: 21/28-day dermal toxicity. Washington, DC: U.S. Environmental Protection Agency, Office of Prevention, Pesticides and Toxic Substances, EPA 712–C–98–201. Washington, DC, USA: USEPA; 1998b.
31.U.S. Environmental Protection Agency (USEPA). Health effects test guidelines OPPTS 870.3250: 90-day dermal toxicity. Washington, DC: U.S. Environmental Protection Agency, Office of Prevention, Pesticides and Toxic Substances, EPA 712–C–98–202. Washington, DC, USA: USEPA; 1998c.
32.U.S. Environmental Protection Agency (USEPA). Health effects test guidelines OPPTS 870.4100: chronic toxicity. Washington, DC: U.S. Environmental Protection Agency, Office of Prevention, Pesticides and Toxic Substances, EPA 712–C–98–210. Washington, DC, USA: USEPA; 1998d.
33.U.S. Environmental Protection Agency (USEPA). Health effects test guidelines OPPTS 870.4200: carcinogenicity. Washington, DC: U.S. Environmental Protection Agency, Office of Prevention, Pesticides and Toxic Substances, EPA 712–C–98–211. Washington, DC, USA: USEPA; 1998e.
34.U.S. Environmental Protection Agency (USEPA). Health effects test guidelines OPPTS 870.4300: combined chronic toxicity/carcinogenicity. Washington, DC: U.S. Environmental Protection Agency, Office of Prevention, Pesticides and Toxic Substances, EPA 712–C–98–212. Washington, DC, USA: USEPA; 1998f.
35.U.S. Environmental Protection Agency (USEPA). Health effects test guidelines OPPTS 870.3700: prenatal developmental toxicity study. Washington, DC: U.S. Environmental Protection Agency, Office of Prevention, Pesticides and Toxic Substances, EPA 712–C–98–207. Washington, DC, USA: USEPA; 1998g.
36.U.S. Environmental Protection Agency (USEPA). Health effects test guidelines OPPTS 870.3800: reproduction and fertility effects. Washington, DC: U.S. Environmental Protection Agency, Office of Prevention, Pesticides and Toxic Substances, EPA 712–C–98–208. Washington, DC, USA: USEPA; 1998h.
37.U.S. Environmental Protection Agency (USEPA). Health effects test guidelines OPPTS 870.7800: immunotoxicity. Washington, DC: U.S. Environmental Protection Agency, Office of Prevention, Pesticides and Toxic Substances, EPA 712–C–98–351. Washington, DC, USA: USEPA; 1998i.
38.U.S. Environmental Protection Agency (USEPA). Health effects test guidelines OPPTS 870.2500: acute dermal irritation. Washington, DC: U.S. Environmental Protection Agency, Office of Prevention, Pesticides and Toxic Substances, EPA 712–C–98–196. Washington, DC, USA: USEPA; 1998j.
39.U.S. Environmental Protection Agency (USEPA). Health effects test guidelines OPPTS 870.2600: skin sensitization. Washington, DC: U.S. Environmental Protection Agency, Office of Prevention, Pesticides and Toxic Substances, EPA 712–C–03–197. Washington, DC, USA: USEPA; 2003.
40.U.S. Environmental Protection Agency (USEPA). Risk assessment guidance for superfund. Vol. I: Human health evaluation manual. Washington, DC: U.S. Environmental Protection Agency, Office of Superfund Remediation and Technology Innovation, EPA/540/R/99/005. Washington, DC, USA: USEPA; 2004
41.U.S. Environmental Protection Agency (USEPA). 69 Fed. Reg. 22402. Environmental Protection Agency: in vitro dermal absorption rate testing of certain chemicals of interest to the Occupational Safety and Health Administration; final rule. Washington, DC, USA: USEPA; 2004.
42.Organisation for Economic Cooperation and Development (OECD). OECD guideline for testing of chemicals 410: repeated dose dermal toxicity—21/28-day study. Paris, France: OECD; 1981a.
43.Organisation for Economic Cooperation and Development (OECD). OECD guideline for testing of chemicals 411: subchronic dermal toxicity—90-day study. Paris, France: OECD; 1981b.
44.Organisation for Economic Cooperation and Development (OECD). OECD guideline for testing of chemicals 452: chronic toxicity studies. Paris, France: OECD; 1981c.
45.Organisation for Economic Cooperation and Development (OECD). OECD guideline for testing of chemicals 451: carcinogenicity studies. Paris, France: OECD; 1981d.
46.Organisation for Economic Cooperation and Development (OECD). OECD guideline for testing of chemicals 453: combined chronic toxicity/carcinogenicity studies. Paris, France: OECD; 1981e.
47.Organisation for Economic Cooperation and Development (OECD). OECD guideline for testing of chemicals 402: acute dermal toxicity. Paris, France: OECD; 1987.
48.Organisation for Economic Cooperation and Development (OECD). OECD guideline for testing of chemicals 406: skin sensitization. Paris, France: OECD; 1992.
49.Organisation for Economic Cooperation and Development (OECD). OECD proposal for a draft new guideline for the testing of chemicals: acute dermal irritation study in human volunteers. Paris, France: OECD; 1997.
50.Organisation for Economic Cooperation and Development (OECD). OECD Series on Testing and Assessment No. 33: harmonized integrated classification system for human health and environmental hazards of chemical substances and mixtures. ENV/JM/MONO(2001)6. Paris, France: Organisation for Economic Cooperation and Development, Environment Directorate, Joint Meeting of the Chemicals Committee and the Working Party on Chemicals, Pesticides and Biotechnology. Paris, France: OECD; 2001a.
51.Organisation for Economic Cooperation and Development (OECD). OECD guideline for testing of chemicals 414: prenatal developmental toxicity study. Paris, France: OECD; 2001b.
52.Organisation for Economic Cooperation and Development (OECD). OECD guideline for testing of chemicals 416: two-generation reproduction toxicity study. Paris, France: OECD; 2001c.
53.Organisation for Economic Cooperation and Development (OECD). OECD guideline for testing of chemicals 404: acute dermal irritation/corrosion. Paris, France: OECD; 2002a.
54.Organisation for Economic Cooperation and Development (OECD). OECD guideline for testing of chemicals 429: skin sensitization—local lymph node assay. Paris, France: OECD; 2002b.
55.Organisation for Economic Cooperation and Development (OECD). OECD guideline for testing of chemicals 432: in vitro 3T3 NRU phototoxicity test. Paris, France: OECD; 2004a.
56.Organisation for Economic Cooperation and Development (OECD). OECD guideline for testing of chemicals 431: in vitro skin corrosion—human skin model test. Paris, France: OECD; 2004b.
57.Organisation for Economic Cooperation and Development (OECD). OECD guideline for testing of chemicals 430: in vitro skin corrosion—Transcutaneous electrical resistance test (TER). Paris, France: OECD; 2004c.
58.Organisation for Economic Cooperation and Development (OECD). OECD Series on Testing and Assessment No. 28: guidance document for the conduct of skin absorption studies. ENV/JM/MONO(2004)2. Paris, France: Organisation for Economic Cooperation and Development, Environment Directorate, Joint Meeting of the Chemicals Committee and the Working Party on Chemicals, Pesticides and Biotechnology. Paris, France: OECD; 2004d.
59.Organisation for Economic Cooperation and Development (OECD). OECD guideline for testing of chemicals 428: skin absorption—in vitro method. Paris, France: OECD; 2004e.
60.European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC). Skin sensitisation testing for the purpose of hazard identification and risk assessment. ECETOC Monograph No.29. Brussels, Belgium: ECETOC; 2000.
61.European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC). Use of human data in hazard classification for irritation and sensitization. ECETOC Monograph No.32. Brussels, Belgium: ECETOC; 2002.
62.Sartorelli P, Ahlers HW, Alanko K, Chen CP, Cherrie JW, Drexler H, Kezic S, Johanson G, Filon FL, Maina G, Montomoli L, Nielsen JB. 2007. How to improve skin notation. Position paper from a workshop. Regulatory Toxicology and Pharmacology 49(3):301-307.
63.McDougal JN and Boeniger MF. Methods for assessing risks of dermal exposures in the workplace. Crit Rev Toxicol 2002; 32:291-327.
64.European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC). Examination of a proposed skin notation strategy. ECETOC Special Report No.15. Brussels, Belgium: ECETOC; 1998.
65.Frasch H, Dotson G, Bunge A, Chen CP, Cherrie JW, Kasting G, Kissel J, Sahmel J, Semple S, and Wilkinson S. Analysis of finite dose dermal absorption data: Implications for dermal exposure assessment. J Expo Sci Environ Epidemiol advance online publication 29 May 2013; doi: 10.1038/jes.2013.23.
66.Brown SL, Rossi JE. A Simple method for estimating dermal absorption of chemicals in water. Chemosphere 1989; 19:1989-2001.
67.Fiserova-Bergerova V, Pierce JT, and Droz PO. Dermal absorption potential of industrial chemicals: criteria for skin notation. Am J Ind Med 1990; 17:617-35.
68.McKone TE, Howd RA. Estimating dermal uptake of nonionic organic chemicals from water and soil: I. unified fugacity-based models for risk assessments. Risk Anal 1992; 12:543-57.
69.Guy RH, Potts RO. Penetration of industrial chemicals across the skin: a predictive model. Am J Ind Med 1993; 23:711-9.
70.Robinson PJ. A composite model for predicting dermal penetration in vivo. Cincinnati, OH, USA: The Proctor & Gamble Company, Human and Environmental Safety Division; 1993.
71.Chang YC, Chen CP, and Chen CC. Predicting skin permeability of chemical substances using a quantitative structure-activity relationship. Procedia Engineering 2012; 45:875-9.
72.Potts RO, Guy RH. Predicting skin permeability. Pharmaceutical Res 1992; 9:663-9.
73.Potts RO, Guy RH. A predictive algorithm for skin permeability: the effects of molecular size and hydrogen bond activity. Pharmaceutical Res 1995; 12:1628-33.
74.Talete srl. DRAGON User Manual. DRAGON for Windows and Linux 2007, Version 5.5, available from: http://www.talete.mi.it/. Milano, Italy: Talete srl.; 2007.
75.Lien EJ, Gao H. QSAR analysis of skin permeability of various drugs in man as compared to in vivo and in vitro studies in rodents. Pharmaceutical Res 1995; 12:583-7.
76.Barratt DM. Quantitative structure-activity relationships for skin permeability. Toxicol in Vitro 1995; 9:27-37.
77.Abraham MH, Chadha HS, and Mitchell RC. The factors that influence skin penetration of solutes. J Pharm Pharmacol 1995; 47: 8-16.
78.Abraham MH, Chadha HS, Martins F, Mitchell RC, Bradbury MW, and Gratton JA. Hydrogen bonding part 46: a review of the correlation and prediction of transport properties by an LFER method: physicochemical properties, brain penetration and skin permeability. Pesticide Sci 1999; 55:78-88.
79.Patel H, ten Berge W, Cronin MTD. Quantitative structure–activity relationships (QSARs) for the prediction of skin permeation of exogenous chemicals. Chemosphere 2002; 48:603-13.
80.Mitragotri S. A theoretical analysis of permeation of small hydrophobic solutes across the skin based on scaled particle theory. J Pharm Sci 2002; 91:754-57.
81.Lian G, Chen L, Han L. An evaluation of mathematical models for predicting skin permeability. J Pharmaceutical Sci 2008; 97:584-98.
82.National Institute for Occupational Safety and Health (NIOSH). Documentation for Immediately Dangerous to Life or Health concentrations (IDLH). NTIS Pub. No. PB-94-195047. Cincinnati, OH, USA: NIOSH; 1995.
83.張晏青,陳振菶。工業化學毒物皮膚暴露危害預測模式—適用一般作業環境暴露與短期高濃度暴露之模式比較。屏東,台灣:中華民國環境工程學會2010年會暨工安衛與防災研討會;2010年11月13日。
84.Flynn GL. Physicochemical determinants of skin absorption. In: Gerrity TR, Henry CJ, editors. Principles of Route-to-Route Extrapolation for Risk Assessment. New York, NY, USA: Elsevier Sci. Pub. Co.; 1990. pp. 93-127.
85.Demuth, H.; Beale, M.; Hagan, M. NeuralNetwork Toolbox─User’s Guide. Version 5. The MathWorks. Inc. 2006.
86.Hypercube Inc. Reference Manual. HyperChem® Release 8.0 for Windows® Molecular Modeling System. Waterloo, ON, Canada: Hypercube Inc.; 2008.
87.The MathWorks, Inc. MATLAB Statistical Toolbox v7.7 – User Guide. Natick, MA, USA: The MathWorks, Inc.; 2009.
88.Chen CC, Liaw HJ, Tsai YJ. Prediction of Flash Point of Organosilicon Compounds Using Quantitative Structure Property Relationship Approach. Ind Eng Chem Res 2010; 49:12702-8.
89.National Institute for Occupational Safety and Health (NIOSH). Registry of Toxic Effects of Chemical Substances (RTECS®) Database. CD-ROM. Cincinnati, OH, USA: NIOSH; 2001.
90.Syracuse Research Corporation (SRC). PhysProp Database, available from: http://www.syrres.com/esc/physprop.htm. Arlington, VA, USA: SRC; 2010.
91.American Conference of Governmental Industrial Hygienists (ACGIH). 2013 TLVs® and BEIs® Based on the Documentation of the Threshold Limit Values for Chemical Substances and Physical Agents & Biological Exposure Indices. Cincinnati, OH, USA: ACGIH; 2013.
92.Occupational Safety and Health Administration (OSHA). The OSHA permissible exposure limits (PELs), OSHA General Industry Air Contaminants Standard (29 CFR 1910.1000), Tables Z-1, Z-2, and Z-3. Washington, DC: OSHA; 1989.
93.National Institute for Occupational Safety and Health (NIOSH). NIOSH Pocket Guide to Chemical Hazards (NPG), available from: http://www.cdc.gov/niosh/npg/search.html. Atlanta, GA: NIOSH; 2010.
94.Health and Safety Executive (HSE). EH40/2005 Workplace exposure limits. London, United Kingdom: HSE; 2013.
95.Deutsche Forschungsgemeinschaft. List of MAK and BAT Values 2012. Report No. 48 of the Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area. Maximum Concentrations and Biological Tolerance Values at the Workplace. Bonn, Federal Republic of Germany: Deutsche Forschungsgemeinschaft; 2012.
96.The Health Council of the Netherlands (Gezondheidsraad). The Health Council of the Netherlands: Healthy working conditions, available from: http://www.gezondheidsraad.nl/en/publications/healthy-working-conditions. The Hague, the Netherlands; 2000-2005.
97.Sosiaali- ja terveysministeriön asetus. Sosiaali- ja terveysministeriön päätöksen mukaisesti säädetään työturvallisuuslain (738/2002). Helsingissä, Finland: Sosiaali- ja terveysministeri; 2011.
98.Arbetsmiljöverkets författningssamling (AFS). Hygieniska gränsvärden Arbetsmiljöverkets föreskrifter och allmänna råd om hygieniska gränsvärden. Stockholm, Sweden: AFS; 2011.
99.The Japan Society for Occupational Health (JSOH). Recommendation of Occupational Exposure Limits (2012-2013). J Occup Health 2012; 54:387-404.
100.Safe Work Australia. Hazardous Substances Information System (HSIS): Search Exposure Standards, accesses: http://hsis.safeworkaustralia.gov.au/ExposureStandards. Canberra, Australia: Safe Work Australia; 2012.
101.Arbeidstilsynet. Veiledning om Administrative normer for forurensning i arbeidsatmosfare. Oslo, Norway: Arbeidstilsynet; 2011.
102.Slawomir Czerczak and Malgorzata Kupczewska. Assignment of Skin Notation for Maximum Allowable Concentration (MAC) List in Poland. Appl Occup Environ Hyg 2002; 17: 187-99.
103.European Union. COMMISSION DIRECTIVE 2000/39/EC of 8 June 2000 establishing a first list of indicative occupational exposure limit values in implementation of Council Directive 98/24/EC on the protection of the health and safety of workers from the risks related to chemical agents at work. Official Journal of the European Union OJ L 142, 16.6.2000, p.47.
104.European Union. COMMISSION DIRECTIVE 2006/15/EC of 7 February 2006 establishing a second list of indicative occupational exposure limit values in implementation of Council Directive 98/24/EC and amending Directives 91/322/EEC and 2000/39/EC. Official Journal of the European Union OJ L 142, 16.6.2000, p. 47.
105.European Union. COMMISSION DIRECTIVE 2009/161/EU of 17 December 2009 establishing a third list of indicative occupational exposure limit values in implementation of Council Directive 98/24/EC and amending Commission Directive 2000/39/EC. Official Journal of the European Union OJ L 38, 9.2.2006, p. 36.
106.The Government of Alberta. Occupational Health and Safety Code 2009. Edmonton, Canada: the Government of Alberta; 2009.
107.The Occupational Health and Safety Regulation (OHSR). Table of exposure limits for chemical and biological substances. British Columbia, Canada: OHSR; 2012.
108.Ministry of Labour. Occupational Exposure Limits (OELs) for Ontario Workplaces. Ontario, Canada: Ministry of Labour; 2013.
109.Officiel du Québec. Règlement sur la santé et la sécurité du travail - Loi sur la santé et la sécurité du travail, Annex I, Part 1, Valeurs d’exposition admissibles des contaminants de l’air. Québec, Canada: Officiel du Québec; 2013.
110.The Belgian Federal Public Service Employment, Labour and Social Dialogue. Liste de valeurs limites d’expositions professionnelle aux agents chimiques. Belgium: The Belgian Federal Public Service Employment, Labour and Social Dialogue; 2002.
111.The OELs in Brazil cover their standard a 48-hour workweek. Quadro I do Anexo 11 da NR-15 Tabela de Limites de Tolerância. Brazil; 2010.
112.中华人民共和国卫生部。中华人民共和国国家职业卫生标准─工作场所有害因素职业接触限值化学有害因素(GBZ 2.1-2007)。北京市,中华人民共和国:中华人民共和国卫生部,2007年。
113.Instituto Nacional de Seguridad e Higiene en el Trabajo (INSHT). Límites de Exposición Profesional para Agentes Químicos en España 2013.
114.National Library of Medicine (NLM). Toxicology Data Network (TOXNET) ChemIDplus Database, available from: http://toxnet.nlm.nih.gov/. Bethesda, MD, USA: NLM; 2011.
115.National Institute of Standards and Technology (NIST). Chemistry WebBook, available from: http://webbook.nist.gov/chemistry/. Gaithersburg, MD, USA: NIST; 2011.
116.ten Berge WF, Zwart A, and Appleman LM. Concentration-time mortality response relationship of irritant and systematically acting vapours and gases. J Haz Mat 1986; 13:301-9.
117.Golbraikh, A.; Tropsha, A. Beware of q2! J Mol Graph Model, 2002; 20:269-276.
118.Fitzpatrick D, Corish J, Hayes B. Modelling skin permeability in risk assessment–the future. Chemosphere 2004; 55:1309-14.
119.Bronaugh RL, Congdon ER, Scheuplein RJ. The effect of cosmetic vehicles on the penetration of n-nitrosodiethanolamine through excised human skin. J Invest Dermatol, 1981; 76:94-6.
120.Franz TJ, Lehman PA, Franz SF, et al. Percutaneous penetration of n-nitrosodiethanolamine through human skin (in vitro): comparison of finite and infinite dose applications from cosmetic vehicles. Fund Appl Toxicol, 1993; 21:213-21.
121.Brain KR, Walters KA, James VJ, et al. Percutaneous penetration of dimethylnitrosamine through human skin in vitro: application from cosmetic vehicles. Food Chem Toxicol, 1995; 33:315-22.
122.Helguera A, Cordeiro M, González M, Pérez M, Ruiz R, Castillo Y. QSAR modeling for predicting carcinogenic potency of nitroso-compounds using 0D-2D molecular descriptors. The 11th International Electronic Conference on Synthetic Organic Chemistry. ECSOC Proceedings ECSOC-11, 2007 November 1-30, Basel, Switzerland.